首页 > 最新文献

Journal of molecular and cellular cardiology plus最新文献

英文 中文
Coxsackie and adenovirus receptor is a novel regulator of inflammatory response in endotoxin-induced failing heart. 柯萨奇和腺病毒受体是内毒素诱导心力衰竭炎症反应的一种新的调节因子。
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-06 DOI: 10.1016/j.jmccpl.2025.100496
Reo Matsumura , Mototsugu Nishii , Haruya Usuku , Masahiro Nakayama , Masaki Hachisuka , Naho Misawa , Ryo Saji , Fumihiro Ogawa , Alan Valaperti , Yoshihiro Ishikawa , Ichiro Takeuchi
The regulatory mechanisms for inflammatory response in the heart to endotoxin, which causes severe cardiac dysfunction, are not fully understood. We hypothesized the involvement of coxsackie and adenovirus receptor (CXADR), which can promote tissue inflammation by potentiating cell-cell adhesion, independent of viral infection, and examined the role of CXADR in endotoxin-induced cardiac dysfunction and its mechanism using an experimental mouse model. Conditional whole-body and endothelium-specific CXADR knockout (W-KO and E-KO, respectively) mice were generated using the Cre-loxP system and administered lipopolysaccharide (LPS) or vehicle alone, like wild-type (WT) mice. Cardiac CXADR increased 12 h after LPS challenge in WT mice, along with improved cardiac dysfunction and reduced cardiac expression of interleukin (IL)-6 and IL-1β. Moreover, W-KO in adult mice worsened cardiac dysfunction and increased expression of these cytokines. Meanwhile, E-KO exhibited the opposite effects, concomitantly reducing myocardial inflammation. Bulk RNA sequencing analysis identified an enriched IL-17 A signaling pathway capable of inducing IL-6 and IL-1β expression in the heart 12 h after LPS challenge. In this heart, E-KO attenuated phosphorylation of p38 but not of upstream mitogen-activated protein kinase kinase (MKK)3/6. Conversely, W-KO augmented phosphorylation of p38, MKK3/6, and NF-κB/p65, which are key drivers of the IL-17 A signaling. Our study is the first to demonstrate that increased CXADR expression plays a dual role as both a pro-inflammatory mediator and an anti-inflammatory protector in endotoxin-induced cardiac dysfunction, possibly by positively or negatively regulating p38 activation depending on its cellular origin. Targeted manipulation of CXADR expression may provide clinical benefits.
心脏对内毒素的炎症反应的调节机制,导致严重的心功能障碍,尚不完全清楚。我们假设柯萨奇和腺病毒受体(CXADR)参与其中,它可以通过增强细胞-细胞粘附而促进组织炎症,独立于病毒感染,并通过实验小鼠模型研究了CXADR在内毒素诱导的心功能障碍中的作用及其机制。使用Cre-loxP系统产生条件全身和内皮特异性CXADR敲除(分别为W-KO和E-KO)小鼠,并像野生型(WT)小鼠一样单独给予脂多糖(LPS)或载体。LPS刺激后12小时,WT小鼠心脏CXADR升高,心功能障碍改善,白细胞介素(IL)-6和IL-1β表达降低。此外,成年小鼠的W-KO加重了心功能障碍,增加了这些细胞因子的表达。同时,E-KO表现出相反的作用,同时减少心肌炎症。大量RNA测序分析发现,在LPS刺激后12小时,一个富集的IL-17 A信号通路能够诱导IL-6和IL-1β的表达。在这个心脏中,E-KO减弱了p38的磷酸化,但没有减弱上游丝裂原活化蛋白激酶(MKK)3/6的磷酸化。相反,W-KO增加了p38、MKK3/6和NF-κB/p65的磷酸化,这是il - 17a信号传导的关键驱动因素。我们的研究首次证明,CXADR表达的增加在内毒素诱导的心功能障碍中扮演着促炎介质和抗炎保护剂的双重角色,可能是通过积极或消极地调节p38的激活,这取决于其细胞来源。有针对性地操纵CXADR表达可能提供临床益处。
{"title":"Coxsackie and adenovirus receptor is a novel regulator of inflammatory response in endotoxin-induced failing heart.","authors":"Reo Matsumura ,&nbsp;Mototsugu Nishii ,&nbsp;Haruya Usuku ,&nbsp;Masahiro Nakayama ,&nbsp;Masaki Hachisuka ,&nbsp;Naho Misawa ,&nbsp;Ryo Saji ,&nbsp;Fumihiro Ogawa ,&nbsp;Alan Valaperti ,&nbsp;Yoshihiro Ishikawa ,&nbsp;Ichiro Takeuchi","doi":"10.1016/j.jmccpl.2025.100496","DOIUrl":"10.1016/j.jmccpl.2025.100496","url":null,"abstract":"<div><div>The regulatory mechanisms for inflammatory response in the heart to endotoxin, which causes severe cardiac dysfunction, are not fully understood. We hypothesized the involvement of coxsackie and adenovirus receptor (CXADR), which can promote tissue inflammation by potentiating cell-cell adhesion, independent of viral infection, and examined the role of CXADR in endotoxin-induced cardiac dysfunction and its mechanism using an experimental mouse model. Conditional whole-body and endothelium-specific CXADR knockout (W-KO and <em>E</em>-KO, respectively) mice were generated using the Cre-loxP system and administered lipopolysaccharide (LPS) or vehicle alone, like wild-type (WT) mice. Cardiac CXADR increased 12 h after LPS challenge in WT mice, along with improved cardiac dysfunction and reduced cardiac expression of interleukin (IL)-6 and IL-1β. Moreover, W-KO in adult mice worsened cardiac dysfunction and increased expression of these cytokines. Meanwhile, <em>E</em>-KO exhibited the opposite effects, concomitantly reducing myocardial inflammation. Bulk RNA sequencing analysis identified an enriched IL-17 A signaling pathway capable of inducing IL-6 and IL-1β expression in the heart 12 h after LPS challenge. In this heart, <em>E</em>-KO attenuated phosphorylation of p38 but not of upstream mitogen-activated protein kinase kinase (MKK)3/6. Conversely, W-KO augmented phosphorylation of p38, MKK3/6, and NF-κB/p65, which are key drivers of the IL-17 A signaling. Our study is the first to demonstrate that increased CXADR expression plays a dual role as both a pro-inflammatory mediator and an anti-inflammatory protector in endotoxin-induced cardiac dysfunction, possibly by positively or negatively regulating p38 activation depending on its cellular origin. Targeted manipulation of CXADR expression may provide clinical benefits.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100496"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer-driven cytokine immunomodulation ameliorates cardiac function and suppresses fibrosis 癌症驱动的细胞因子免疫调节改善心功能和抑制纤维化
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-12 DOI: 10.1016/j.jmccpl.2025.100493
Laris Achlaug , Lama Awwad , Irina Langier Goncalves , Sharon Aviram , Ariella Glasner , Ami Aronheim
Heart failure remains a leading cause of morbidity and mortality worldwide, with limited progress in the development of novel therapies. It has been demonstrated that tumor growth improves cardiac function and reduces myocardial fibrosis in mouse models of heart failure. It is clear that cancer cell implantation is not a possible therapeutic strategy for heart failure. Therefore, we further studied the underlying mechanism involved, with the objective of demonstrating its broad therapeutic applicability. We show that a single intravenous injection of serum from tumor-bearing mice rapidly augments left-ventricular fractional shortening and suppresses fibrosis in the heart, diaphragm, and skeletal muscles. Cytokine profiling identified IFNγ and TNFα as essential mediators secreted downstream of natural killer (NK) cell activation. Purified recombinant IFNγ and TNFα mimic the serum effect, polarizing cardiac and skeletal macrophages toward an anti-inflammatory, reparative state. We further show that macrophage depletion abrogates the observed beneficial effect, confirming their critical role. Our findings define a novel NK cell–macrophage cytokine axis that reverses cardiac dysfunction and fibrosis in pressure-overload (transverse aortic constriction) and ATF3-transgenic heart failure models. Together, these findings define a novel host-tumor microenvironment response through cytokine secretion, which leads to cardiac repair and dissolution of fibrosis. This work presents a novel therapeutic strategy for harnessing innate immune cells in the treatment of heart failure and fibrotic disease.
心力衰竭仍然是世界范围内发病率和死亡率的主要原因,在开发新疗法方面进展有限。在心力衰竭小鼠模型中,已经证明肿瘤生长可以改善心功能并减少心肌纤维化。很明显,癌细胞植入不是心力衰竭的一种可能的治疗策略。因此,我们进一步研究了相关的潜在机制,目的是证明其广泛的治疗适用性。我们的研究表明,单次静脉注射荷瘤小鼠血清可迅速增加左心室缩短,并抑制心脏、膈肌和骨骼肌的纤维化。细胞因子分析发现IFNγ和TNFα是自然杀伤(NK)细胞激活下游分泌的重要介质。纯化重组IFNγ和TNFα模拟血清效应,极化心脏和骨骼巨噬细胞走向抗炎、修复状态。我们进一步表明,巨噬细胞耗竭抵消了观察到的有益作用,证实了它们的关键作用。我们的研究结果定义了一种新的NK细胞-巨噬细胞细胞因子轴,可以逆转压力过载(主动脉横缩)和atf3转基因心力衰竭模型中的心功能障碍和纤维化。总之,这些发现定义了一种新的宿主-肿瘤微环境反应,通过细胞因子分泌,导致心脏修复和纤维化溶解。这项工作提出了一种利用先天免疫细胞治疗心力衰竭和纤维化疾病的新治疗策略。
{"title":"Cancer-driven cytokine immunomodulation ameliorates cardiac function and suppresses fibrosis","authors":"Laris Achlaug ,&nbsp;Lama Awwad ,&nbsp;Irina Langier Goncalves ,&nbsp;Sharon Aviram ,&nbsp;Ariella Glasner ,&nbsp;Ami Aronheim","doi":"10.1016/j.jmccpl.2025.100493","DOIUrl":"10.1016/j.jmccpl.2025.100493","url":null,"abstract":"<div><div>Heart failure remains a leading cause of morbidity and mortality worldwide, with limited progress in the development of novel therapies. It has been demonstrated that tumor growth improves cardiac function and reduces myocardial fibrosis in mouse models of heart failure. It is clear that cancer cell implantation is not a possible therapeutic strategy for heart failure. Therefore, we further studied the underlying mechanism involved, with the objective of demonstrating its broad therapeutic applicability. We show that a single intravenous injection of serum from tumor-bearing mice rapidly augments left-ventricular fractional shortening and suppresses fibrosis in the heart, diaphragm, and skeletal muscles. Cytokine profiling identified IFNγ and TNFα as essential mediators secreted downstream of natural killer (NK) cell activation. Purified recombinant IFNγ and TNFα mimic the serum effect, polarizing cardiac and skeletal macrophages toward an anti-inflammatory, reparative state. We further show that macrophage depletion abrogates the observed beneficial effect, confirming their critical role. Our findings define a novel NK cell–macrophage cytokine axis that reverses cardiac dysfunction and fibrosis in pressure-overload (transverse aortic constriction) and ATF3-transgenic heart failure models. Together, these findings define a novel host-tumor microenvironment response through cytokine secretion, which leads to cardiac repair and dissolution of fibrosis. This work presents a novel therapeutic strategy for harnessing innate immune cells in the treatment of heart failure and fibrotic disease.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100493"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FABP3 and FABP4 promote lipid peroxidation injury during static cold storage of donor heart: Insights from multi-omics and therapeutic targeting FABP3和FABP4促进供体心脏静态冷藏过程中的脂质过氧化损伤:来自多组学和靶向治疗的见解
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-13 DOI: 10.1016/j.jmccpl.2025.100497
Yu Feng , Yongbu Peng , Jincheng Hou , Zihao Wang , Junlin Lai , Tixiusi Xiong , Jiawei Shi , Yixuan Wang , Wai Yen Yim , Yuqi Chen , Nianguo Dong

Objectives

To clarify the mechanism of myocardial injury associated with lipid peroxidation and the role of fatty acid binding proteins FABP3/4 during Static cold storage (SCS) of donor hearts.

Methods

Multi-omics analysis included mouse myocardial metabolomics and transcriptomics, proteomics of cardiac preservation solution in SCS injury. Lipid peroxidation was detected by malondialdehyde, transmission electron microscopy (TEM), and fluorescent probes. Lipid peroxidation antagonist MitoQ was examined by TEM. FABP3/4 were analyzed by combining the proteomic data of first perfusion serum from human donor hearts with those of mouse myocardial SCS solution. Overexpressing FABP3/4 were evaluated by detecting ROS and apoptosis via flow cytometry. snRNA-seq revealed the cellular landscape of SCS injury in pig cardiomyocytes.

Results

Multi-omics analysis of the SCS injury model revealed significant changes in lipid metabolism. Disturbed lipid metabolism and peroxidation were demonstrated in mouse SCS injury model and cell model. MitoQ attenuated lipid peroxidation and antagonized cardiac SCS injury. FABP3/4 were released during SCS and promoted injury in cardiomyocytes. In SCS solution, FABP3/4 expression were improved in both short-term and long-term SCS. In myocardial tissue, FABP3 expression decreased during short-term SCS and then gradually increased after long-term SCS. FABP4 expression were first upregulated and then decreased, remaining stable during long-term SCS. Pig cardiomyocytes showed low FABP3 and high FABP4 expression during short-term SCS.

Conclusion

Disturbed lipid metabolism and peroxidation occur during SCS of hearts. FABP3/4 promote lipid uptake and aggravate SCS damage. FABP3/4 should be further investigated as potential therapeutic targets for SCS injury during heart transplantation.
目的探讨脂质过氧化引起心肌损伤的机制及脂肪酸结合蛋白FABP3/4在供心静态冷藏过程中的作用。方法多组学分析包括小鼠心肌代谢组学、转录组学、心肌保存液蛋白质组学等。采用丙二醛、透射电镜(TEM)和荧光探针检测脂质过氧化。用透射电镜检测脂质过氧化拮抗剂MitoQ。结合人供心首次灌注血清和小鼠心肌SCS溶液的蛋白质组学数据分析FABP3/4。流式细胞术检测ROS和细胞凋亡,评价过表达FABP3/4的小鼠。snRNA-seq揭示了猪心肌细胞SCS损伤的细胞景观。结果对SCS损伤模型进行多组学分析,发现脂质代谢发生显著变化。小鼠SCS损伤模型和细胞模型均出现脂质代谢紊乱和过氧化现象。MitoQ减轻脂质过氧化和拮抗心脏SCS损伤。FABP3/4在SCS过程中释放,促进心肌细胞损伤。在SCS溶液中,FABP3/4的表达在短期和长期SCS中均有提高。在心肌组织中,FABP3的表达在短期SCS期间降低,在长期SCS后逐渐升高。FABP4表达先上调后降低,在长期SCS中保持稳定。短期SCS期间,猪心肌细胞FABP3低表达,FABP4高表达。结论心脏SCS存在脂质代谢紊乱和过氧化作用。FABP3/4促进脂质摄取,加重SCS损伤。应进一步研究FABP3/4作为心脏移植过程中SCS损伤的潜在治疗靶点。
{"title":"FABP3 and FABP4 promote lipid peroxidation injury during static cold storage of donor heart: Insights from multi-omics and therapeutic targeting","authors":"Yu Feng ,&nbsp;Yongbu Peng ,&nbsp;Jincheng Hou ,&nbsp;Zihao Wang ,&nbsp;Junlin Lai ,&nbsp;Tixiusi Xiong ,&nbsp;Jiawei Shi ,&nbsp;Yixuan Wang ,&nbsp;Wai Yen Yim ,&nbsp;Yuqi Chen ,&nbsp;Nianguo Dong","doi":"10.1016/j.jmccpl.2025.100497","DOIUrl":"10.1016/j.jmccpl.2025.100497","url":null,"abstract":"<div><h3>Objectives</h3><div>To clarify the mechanism of myocardial injury associated with lipid peroxidation and the role of fatty acid binding proteins FABP3/4 during Static cold storage (SCS) of donor hearts.</div></div><div><h3>Methods</h3><div>Multi-omics analysis included mouse myocardial metabolomics and transcriptomics, proteomics of cardiac preservation solution in SCS injury. Lipid peroxidation was detected by malondialdehyde, transmission electron microscopy (TEM), and fluorescent probes. Lipid peroxidation antagonist MitoQ was examined by TEM. FABP3/4 were analyzed by combining the proteomic data of first perfusion serum from human donor hearts with those of mouse myocardial SCS solution. Overexpressing FABP3/4 were evaluated by detecting ROS and apoptosis via flow cytometry. snRNA-seq revealed the cellular landscape of SCS injury in pig cardiomyocytes.</div></div><div><h3>Results</h3><div>Multi-omics analysis of the SCS injury model revealed significant changes in lipid metabolism. Disturbed lipid metabolism and peroxidation were demonstrated in mouse SCS injury model and cell model. MitoQ attenuated lipid peroxidation and antagonized cardiac SCS injury. FABP3/4 were released during SCS and promoted injury in cardiomyocytes. In SCS solution, FABP3/4 expression were improved in both short-term and long-term SCS. In myocardial tissue, FABP3 expression decreased during short-term SCS and then gradually increased after long-term SCS. FABP4 expression were first upregulated and then decreased, remaining stable during long-term SCS. Pig cardiomyocytes showed low FABP3 and high FABP4 expression during short-term SCS.</div></div><div><h3>Conclusion</h3><div>Disturbed lipid metabolism and peroxidation occur during SCS of hearts. FABP3/4 promote lipid uptake and aggravate SCS damage. FABP3/4 should be further investigated as potential therapeutic targets for SCS injury during heart transplantation.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100497"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Signaling pathway alterations in hearts of a porcine model harboring a β-myosin heavy chain (MYH7-R403Q) gene variant 含有β-肌球蛋白重链(MYH7-R403Q)基因变异的猪模型心脏信号通路的改变
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-04 DOI: 10.1016/j.jmccpl.2025.100495
Chad M. Warren , David M. Ryba , Gail E. Geist , Aileen Castro Coronado , Beata M. Wolska , Paul H. Goldspink , R. John Solaro
The disease-causing myosin variant (MYH7-403Q) is linked to hypertrophic cardiomyopathy (HCM). We carried out a research study of signaling pathways in heart samples from control wild-type (WT) GE Yucatán mini-pigs and their littermates harboring the gene variant, MYH7-R403Q. Our approach permits the determination of adverse signaling pathways involved in different regions of a translationally relevant heart without the effects of intervention. We examined the left ventricular free wall (LV), endocardium (EN), and coronary arteries (CA) from 5 transgenic and 5 wild-type mini-pig littermates to determine alterations in global phosphorylation and protein abundance. Digested peptides from 6 to 7 months old mixed-sex mini-pigs were isobarically labeled; 95 % were phospho-enriched, and 5 % were used as the unmodified (total) fraction. The phospho-enriched and unmodified fractions were injected into an Orbitrap Fusion Lumos and analyzed using PEAKS Studio and Ingenuity Pathway Analysis. Surprisingly, we found no significant changes in the phospho-peptide and unmodified protein abundances in CA. Compared to WT, both LV and EN samples displayed minor changes in phosphorylation and significant changes in unmodified proteins. Bioinformatic analysis revealed that pathways associated with mechano-signaling between cardiomyocytes and the extracellular matrix and inflammation were altered in LV and EN samples. In addition, EN samples had larger differences in pathways related to metabolic dysfunction compared to LV. Our findings provide a translational understanding of signaling pathways altered in the MYH7-R403Q gene variant.
引起疾病的肌球蛋白变体(MYH7-403Q)与肥厚性心肌病(HCM)有关。我们对携带MYH7-R403Q基因变体的对照野生型(WT) GE Yucatán迷你猪及其窝仔的心脏样本的信号通路进行了研究。我们的方法允许在没有干预影响的情况下确定涉及翻译相关心脏不同区域的不良信号通路。我们检测了5只转基因猪和5只野生型迷你猪的左心室游离壁(LV)、心内膜(EN)和冠状动脉(CA),以确定其整体磷酸化和蛋白质丰度的变化。对6 ~ 7月龄混合型小型猪的消化肽进行等压标记;95%是富磷的,5%是未修饰的(总)部分。将富磷和未修饰的部分注入Orbitrap Fusion Lumos,并使用PEAKS Studio和Ingenuity Pathway Analysis进行分析。令人惊讶的是,我们发现CA的磷酸化肽和未修饰蛋白丰度没有显著变化。与WT相比,LV和EN样品的磷酸化变化较小,未修饰蛋白的变化显著。生物信息学分析显示,在LV和EN样本中,心肌细胞与细胞外基质和炎症之间的机械信号通路发生了改变。此外,与LV相比,EN样本在与代谢功能障碍相关的途径上存在更大的差异。我们的研究结果提供了对MYH7-R403Q基因变异中信号通路改变的翻译理解。
{"title":"Signaling pathway alterations in hearts of a porcine model harboring a β-myosin heavy chain (MYH7-R403Q) gene variant","authors":"Chad M. Warren ,&nbsp;David M. Ryba ,&nbsp;Gail E. Geist ,&nbsp;Aileen Castro Coronado ,&nbsp;Beata M. Wolska ,&nbsp;Paul H. Goldspink ,&nbsp;R. John Solaro","doi":"10.1016/j.jmccpl.2025.100495","DOIUrl":"10.1016/j.jmccpl.2025.100495","url":null,"abstract":"<div><div>The disease-causing myosin variant (MYH7-403Q) is linked to hypertrophic cardiomyopathy (HCM). We carried out a research study of signaling pathways in heart samples from control wild-type (WT) GE Yucatán mini-pigs and their littermates harboring the gene variant, MYH7-R403Q. Our approach permits the determination of adverse signaling pathways involved in different regions of a translationally relevant heart without the effects of intervention. We examined the left ventricular free wall (LV), endocardium (EN), and coronary arteries (CA) from 5 transgenic and 5 wild-type mini-pig littermates to determine alterations in global phosphorylation and protein abundance. Digested peptides from 6 to 7 months old mixed-sex mini-pigs were isobarically labeled; 95 % were phospho-enriched, and 5 % were used as the unmodified (total) fraction. The phospho-enriched and unmodified fractions were injected into an Orbitrap Fusion Lumos and analyzed using PEAKS Studio and Ingenuity Pathway Analysis. Surprisingly, we found no significant changes in the phospho-peptide and unmodified protein abundances in CA. Compared to WT, both LV and EN samples displayed minor changes in phosphorylation and significant changes in unmodified proteins. Bioinformatic analysis revealed that pathways associated with mechano-signaling between cardiomyocytes and the extracellular matrix and inflammation were altered in LV and EN samples. In addition, EN samples had larger differences in pathways related to metabolic dysfunction compared to LV. Our findings provide a translational understanding of signaling pathways altered in the MYH7-R403Q gene variant.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100495"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rab10 plays a protective role in the development of pathological cardiac hypertrophy Rab10在病理性心肌肥厚的发生发展中起保护作用
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-10-31 DOI: 10.1016/j.jmccpl.2025.100494
Fang Xu , Min Wu , Yihan Wang , Haiyan Luo , Xiaobo Gao , Song Lai , Cailing Lu
Prolonged cardiac hypertrophy is a main risk factor for heart failure (HF). During cardiac hypertrophy remodelling, there is an increase in protein synthesis, as well as the trafficking and localization of proteins to their functional sites. Rab GTPases, which are key regulators of vesicular formation, movement, and fusion, play a crucial role in these processes. In this study, we identified Rab10, a small GTPase belonging to the Rab family, as a novel regulator to inhibit cardiac hypertrophy. Cardiomyocyte hypertrophy was induced by Ang II or pressure overload in primary neonatal rat cardiomyocytes (NRCMs) or mouse model. We found that Rab10 expression was downregulated in NRCMs or murine hearts after hypertrophic stress. Rab10 overexpression attenuated cardiomyocyte hypertrophy, whereas its silencing exacerbated the phenotype, demonstrating its essential antihypertrophic role in vitro. To determine the in vivo role of Rab10 in the heart, we generated cardiac-specific Rab10-overexpressing transgenic mice (TG). When subjected to Ang II infusion or pressure overload, Rab10 TG mice displayed an improved contractile function and attenuated hypertrophic remodelling. In contrast, AAV9-mediated cardiac-specific knockdown of Rab10 significantly aggravated pressure overload-induced cardiomyocyte hypertrophy. Mechanically, Rab10 suppressed the phosphorylation of ERK1/2 and AKT, thereby attenuating the development cardiac hypertrophy. Additionally, we demonstrated that Rab10 was post-transcriptionally downregulated by miR-199a. In summary, our findings revealed a novel role for Rab10 in pathogenic cardiac hypertrophy and suggest that Rab10 may be a potential therapeutic target for cardiac hypertrophic.
心脏肥厚延长是心力衰竭的主要危险因素。在心肌肥厚重塑过程中,蛋白质合成增加,蛋白质转运和定位到其功能位点。Rab gtpase是囊泡形成、运动和融合的关键调节因子,在这些过程中起着至关重要的作用。在这项研究中,我们发现Rab10,一个属于rabb家族的小GTPase,作为一种新的抑制心脏肥厚的调节剂。在初代新生大鼠心肌细胞(NRCMs)或小鼠模型中,angii或压力过载诱导心肌细胞肥大。我们发现,在肥厚应激后nrcm或小鼠心脏中Rab10的表达下调。Rab10过表达减轻心肌细胞肥厚,而其沉默加剧了表型,在体外证明了其重要的抗肥厚作用。为了确定Rab10在心脏中的体内作用,我们培育了心脏特异性Rab10过表达转基因小鼠(TG)。当接受Ang II输注或压力过载时,Rab10 TG小鼠表现出改善的收缩功能和减轻的肥厚重塑。相反,aav9介导的心脏特异性敲低Rab10显著加重了压力过载引起的心肌细胞肥大。机械上,Rab10抑制ERK1/2和AKT的磷酸化,从而减轻心肌肥厚的发生。此外,我们证明Rab10在转录后被miR-199a下调。总之,我们的研究结果揭示了Rab10在致病性心脏肥厚中的新作用,并提示Rab10可能是心脏肥厚的潜在治疗靶点。
{"title":"Rab10 plays a protective role in the development of pathological cardiac hypertrophy","authors":"Fang Xu ,&nbsp;Min Wu ,&nbsp;Yihan Wang ,&nbsp;Haiyan Luo ,&nbsp;Xiaobo Gao ,&nbsp;Song Lai ,&nbsp;Cailing Lu","doi":"10.1016/j.jmccpl.2025.100494","DOIUrl":"10.1016/j.jmccpl.2025.100494","url":null,"abstract":"<div><div>Prolonged cardiac hypertrophy is a main risk factor for heart failure (HF). During cardiac hypertrophy remodelling, there is an increase in protein synthesis, as well as the trafficking and localization of proteins to their functional sites. Rab GTPases, which are key regulators of vesicular formation, movement, and fusion, play a crucial role in these processes. In this study, we identified Rab10, a small GTPase belonging to the Rab family, as a novel regulator to inhibit cardiac hypertrophy. Cardiomyocyte hypertrophy was induced by Ang II or pressure overload in primary neonatal rat cardiomyocytes (NRCMs) or mouse model. We found that Rab10 expression was downregulated in NRCMs or murine hearts after hypertrophic stress. Rab10 overexpression attenuated cardiomyocyte hypertrophy, whereas its silencing exacerbated the phenotype, demonstrating its essential antihypertrophic role <em>in vitro</em>. To determine the <em>in vivo</em> role of Rab10 in the heart, we generated cardiac-specific Rab10-overexpressing transgenic mice (TG). When subjected to Ang II infusion or pressure overload, Rab10 TG mice displayed an improved contractile function and attenuated hypertrophic remodelling. In contrast, AAV9-mediated cardiac-specific knockdown of Rab10 significantly aggravated pressure overload-induced cardiomyocyte hypertrophy. Mechanically, Rab10 suppressed the phosphorylation of ERK1/2 and AKT, thereby attenuating the development cardiac hypertrophy. Additionally, we demonstrated that Rab10 was post-transcriptionally downregulated by miR-199a. In summary, our findings revealed a novel role for Rab10 in pathogenic cardiac hypertrophy and suggest that Rab10 may be a potential therapeutic target for cardiac hypertrophic.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100494"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145520323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age, sex, and vessel region affect the vasomotor function and gene expression signature of the aorta in mice 年龄、性别和血管区域影响小鼠主动脉血管舒缩功能和基因表达特征
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-10-19 DOI: 10.1016/j.jmccpl.2025.100491
Lars Saemann , Lotta Hartrumpf , Adrian-Iustin Georgevici , Sabine Pohl , Anne Großkopf , Kristin Wächter , Yuxing Guo , Andreas Simm , Gábor Szabó

Introduction

Vascular aging is associated with endothelial dysfunction, changes in vascular elasticity or stiffness, and the prevalence of cardiovascular diseases. Aging differs by sex. The effects of age, sex, and vessel region on arterial vasomotor function and gene expression signatures have not been explored yet. Thus, we investigated contraction, relaxation, and endothelial integrity, as well as gene expression, in the proximal and distal segments of the thoracic aorta in 6- and 18-month-old mice.

Materials and methods

Male and female C57BL/6J mice at 6 (n = 11/sex) and 18 (n = 12/sex) months of age were used. Segments of the proximal and distal thoracic aorta were mounted in organ bath chambers. We assessed the maximal receptor-independent contractility using potassium chloride (KCl), endothelial integrity using phenylephrine (PE), endothelial-dependent relaxation using acetylcholine (ACh), and endothelial-independent relaxation using sodium nitroprusside (SNP). Using microarrays, we performed transcriptomics on another 6 six mice of every subgroup.

Results

Endothelial integrity decreases significantly with age in male mice, but only in the proximal segment. The relaxation to ACh decreases with age in both sexes in the proximal and only in female individuals in the descending segment. In females, endothelial-dependent relaxation is higher than in males, in young age, independent of the segment, and in old age, still in the proximal segment. Endothelial-independent relaxation decreases with age only in the distal segment of female subjects. Genes associated with the electron transport chain, crucial for energy production in mitochondria, are decreased by age. The G-protein coupled receptor -G13 alpha subunit- signaling pathway and proteasome degradation, which are crucial for developing and maintaining endothelial integrity, were reduced in the aorta of old mice. Genes involved in endothelial nitric oxide synthesis were especially downregulated in old male mice.

Conclusion

Endothelial integrity and endothelial-dependent relaxation depend on age, sex, and segment of the descending thoracic aorta in mice. Genes associated with endothelial-dependent relaxation, endothelial integrity, and vascular aging change markedly by age, including some sex- and segment-specific differences.
血管老化与内皮功能障碍、血管弹性或硬度的改变以及心血管疾病的患病率有关。衰老因性别而异。年龄、性别和血管区域对动脉血管舒缩功能和基因表达特征的影响尚未探讨。因此,我们研究了6个月和18个月大的小鼠胸主动脉近端和远端段的收缩、松弛、内皮完整性以及基因表达。材料与方法选用6月龄(n = 11/sex)和18月龄(n = 12/sex)的C57BL/6J雄性和雌性小鼠。胸主动脉近段和远段分别安装在器官浴室中。我们使用氯化钾(KCl)评估了最大受体非依赖性收缩力,使用苯肾上腺素(PE)评估了内皮完整性,使用乙酰胆碱(ACh)评估了内皮依赖性松弛,使用硝普钠(SNP)评估了内皮非依赖性松弛。使用微阵列,我们对每个亚组的另外6只小鼠进行转录组学研究。结果随着年龄的增长,雄性小鼠内皮细胞的完整性明显下降,但仅在近端。在两性中,乙酰胆碱的弛豫在近端随着年龄的增长而减少,只有女性个体在下降段。在女性中,内皮依赖性松弛高于男性,在年轻时,独立于节段,在老年时,仍然在近端节段。内皮非依赖性松弛仅在女性受试者的远端节段随年龄而降低。与电子传递链相关的基因,对线粒体的能量产生至关重要,随着年龄的增长而减少。老龄小鼠主动脉中g蛋白偶联受体- g13 α亚基信号通路和蛋白酶体降解减少,这对内皮细胞的发育和维持完整性至关重要。参与内皮细胞一氧化氮合成的基因在老年雄性小鼠中尤其下调。结论小鼠胸降主动脉内皮完整性和内皮依赖性松弛与年龄、性别和节段有关。与内皮依赖性松弛、内皮完整性和血管老化相关的基因随着年龄的增长而发生显著变化,包括一些性别和节段特异性差异。
{"title":"Age, sex, and vessel region affect the vasomotor function and gene expression signature of the aorta in mice","authors":"Lars Saemann ,&nbsp;Lotta Hartrumpf ,&nbsp;Adrian-Iustin Georgevici ,&nbsp;Sabine Pohl ,&nbsp;Anne Großkopf ,&nbsp;Kristin Wächter ,&nbsp;Yuxing Guo ,&nbsp;Andreas Simm ,&nbsp;Gábor Szabó","doi":"10.1016/j.jmccpl.2025.100491","DOIUrl":"10.1016/j.jmccpl.2025.100491","url":null,"abstract":"<div><h3>Introduction</h3><div>Vascular aging is associated with endothelial dysfunction, changes in vascular elasticity or stiffness, and the prevalence of cardiovascular diseases. Aging differs by sex. The effects of age, sex, and vessel region on arterial vasomotor function and gene expression signatures have not been explored yet. Thus, we investigated contraction, relaxation, and endothelial integrity, as well as gene expression, in the proximal and distal segments of the thoracic aorta in 6- and 18-month-old mice.</div></div><div><h3>Materials and methods</h3><div>Male and female C57BL/6J mice at 6 (<em>n</em> = 11/sex) and 18 (<em>n</em> = 12/sex) months of age were used. Segments of the proximal and distal thoracic aorta were mounted in organ bath chambers. We assessed the maximal receptor-independent contractility using potassium chloride (KCl), endothelial integrity using phenylephrine (PE), endothelial-dependent relaxation using acetylcholine (ACh), and endothelial-independent relaxation using sodium nitroprusside (SNP). Using microarrays, we performed transcriptomics on another 6 six mice of every subgroup.</div></div><div><h3>Results</h3><div>Endothelial integrity decreases significantly with age in male mice, but only in the proximal segment. The relaxation to ACh decreases with age in both sexes in the proximal and only in female individuals in the descending segment. In females, endothelial-dependent relaxation is higher than in males, in young age, independent of the segment, and in old age, still in the proximal segment. Endothelial-independent relaxation decreases with age only in the distal segment of female subjects. Genes associated with the electron transport chain, crucial for energy production in mitochondria, are decreased by age. The G-protein coupled receptor -G13 alpha subunit- signaling pathway and proteasome degradation, which are crucial for developing and maintaining endothelial integrity, were reduced in the aorta of old mice. Genes involved in endothelial nitric oxide synthesis were especially downregulated in old male mice.</div></div><div><h3>Conclusion</h3><div>Endothelial integrity and endothelial-dependent relaxation depend on age, sex, and segment of the descending thoracic aorta in mice. Genes associated with endothelial-dependent relaxation, endothelial integrity, and vascular aging change markedly by age, including some sex- and segment-specific differences.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100491"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145363914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metformin alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy 二甲双胍减轻实验性糖尿病心肌病小鼠舒张功能障碍
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-14 DOI: 10.1016/j.jmccpl.2025.100825
Jordan S.F. Chan , Seyed Amirhossein Tabatabaei Dakhili , Nadeen R. Wu , Magnus J. Stenlund , Alexa N. King , Linyue Dong , Indiresh A. Mangra-Bala , Tanin Shafaati , Sally R. Ferrari , Amanda A. Greenwell , Kunyan Yang , Christina T. Saed , Farah Eaton , Keshav Gopal , Gregory R. Steinberg , Jason R.B. Dyck , John R. Ussher
The first line therapy for managing type 2 diabetes (T2D), metformin, has been shown to be cardioprotective in humans and several preclinical models of cardiovascular disease. However, there has been limited interrogation into metformin's effects on diastolic function, a hallmark characteristic of diabetic cardiomyopathy (DbCM), which is becoming increasingly prevalent in people with pre- and early-stage T2D. Accordingly, we aimed to determine the effects of metformin on the pathogenesis of DbCM and hypothesized that treatment with metformin would alleviate diastolic dysfunction in mice with T2D. To induce experimental T2D and DbCM, male C57BL/6J mice were fed a high-fat diet for 12.5 weeks, in combination with a single, low-dose injection of streptozotocin (75 mg/kg) at week 4.5. The animals' drinking water was randomized to include either vehicle control or metformin (3.0 g/L) during the final 7.5 weeks. As expected, metformin treatment improved glycemia with a trend towards a reduction in adiposity in mice with T2D. Using ultrasound echocardiography, we observed that metformin improved diastolic function in mice with T2D as reflected by an increase and a decrease in the e′/a′ and E/e′ ratios, respectively. Furthermore, wheat-germ agglutinin staining indicated that treatment with metformin decreased cardiomyocyte hypertrophy in mice with T2D. However, mice with T2D treated with metformin did not exhibit increases in myocardial adenosine monophosphate-activated protein kinase (AMPK) phosphorylation. Thus, our findings suggest that metformin has salutary actions against DbCM and its associated diastolic dysfunction, which may be independent of its ability to increase AMPK activity.
治疗2型糖尿病(T2D)的一线疗法二甲双胍已被证明对人类和几种心血管疾病的临床前模型具有心脏保护作用。然而,二甲双胍对舒张功能影响的研究有限,舒张功能是糖尿病性心肌病(DbCM)的一个标志性特征,在t2dm前期和早期患者中越来越普遍。因此,我们旨在确定二甲双胍对DbCM发病机制的影响,并假设二甲双胍治疗可以减轻T2D小鼠的舒张功能障碍。为诱导实验性T2D和DbCM,雄性C57BL/6J小鼠12.5周高脂饲粮,4.5周单次低剂量注射链脲佐菌素(75 mg/kg)。在最后7.5周内,将动物的饮用水随机分为对照组和二甲双胍(3.0 g/L)。正如预期的那样,二甲双胍治疗改善了t2dm小鼠的血糖,并有减少肥胖的趋势。通过超声心动图,我们观察到二甲双胍改善了T2D小鼠的舒张功能,反映在e ‘ /a ’和e /e '比值分别增加和减少。此外,小麦胚芽凝集素染色表明,二甲双胍治疗可减少T2D小鼠心肌细胞肥大。然而,二甲双胍治疗的T2D小鼠心肌腺苷单磷酸活化蛋白激酶(AMPK)磷酸化并未增加。因此,我们的研究结果表明,二甲双胍对DbCM及其相关的舒张功能障碍有有益的作用,这可能独立于其增加AMPK活性的能力。
{"title":"Metformin alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy","authors":"Jordan S.F. Chan ,&nbsp;Seyed Amirhossein Tabatabaei Dakhili ,&nbsp;Nadeen R. Wu ,&nbsp;Magnus J. Stenlund ,&nbsp;Alexa N. King ,&nbsp;Linyue Dong ,&nbsp;Indiresh A. Mangra-Bala ,&nbsp;Tanin Shafaati ,&nbsp;Sally R. Ferrari ,&nbsp;Amanda A. Greenwell ,&nbsp;Kunyan Yang ,&nbsp;Christina T. Saed ,&nbsp;Farah Eaton ,&nbsp;Keshav Gopal ,&nbsp;Gregory R. Steinberg ,&nbsp;Jason R.B. Dyck ,&nbsp;John R. Ussher","doi":"10.1016/j.jmccpl.2025.100825","DOIUrl":"10.1016/j.jmccpl.2025.100825","url":null,"abstract":"<div><div>The first line therapy for managing type 2 diabetes (T2D), metformin, has been shown to be cardioprotective in humans and several preclinical models of cardiovascular disease. However, there has been limited interrogation into metformin's effects on diastolic function, a hallmark characteristic of diabetic cardiomyopathy (DbCM), which is becoming increasingly prevalent in people with pre- and early-stage T2D. Accordingly, we aimed to determine the effects of metformin on the pathogenesis of DbCM and hypothesized that treatment with metformin would alleviate diastolic dysfunction in mice with T2D. To induce experimental T2D and DbCM, male C57BL/6J mice were fed a high-fat diet for 12.5 weeks, in combination with a single, low-dose injection of streptozotocin (75 mg/kg) at week 4.5. The animals' drinking water was randomized to include either vehicle control or metformin (3.0 g/L) during the final 7.5 weeks. As expected, metformin treatment improved glycemia with a trend towards a reduction in adiposity in mice with T2D. Using ultrasound echocardiography, we observed that metformin improved diastolic function in mice with T2D as reflected by an increase and a decrease in the e′/a′ and E/e′ ratios, respectively. Furthermore, wheat-germ agglutinin staining indicated that treatment with metformin decreased cardiomyocyte hypertrophy in mice with T2D. However, mice with T2D treated with metformin did not exhibit increases in myocardial adenosine monophosphate-activated protein kinase (AMPK) phosphorylation. Thus, our findings suggest that metformin has salutary actions against DbCM and its associated diastolic dysfunction, which may be independent of its ability to increase AMPK activity.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100825"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial metabolic remodeling and multi-omics profiling identify plasma biomarkers of myocardial infarction 线粒体代谢重塑和多组学分析鉴定心肌梗死的血浆生物标志物
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-13 DOI: 10.1016/j.jmccpl.2025.100827
Selvam Paramasivan , Mitchell C. Lock , Roberto A. Barrero , Paul C. Mills , Janna L. Morrison , Pawel Sadowski
Mitochondrial dysfunction is a hallmark of myocardial infarction (MI), yet the molecular mechanisms linking metabolic reprogramming in the ischemic myocardium to systemic biomarker signatures remain incompletely understood. In this study, we employed a data-independent acquisition mass spectrometry (SWATH-MS) strategy integrating multi-omics analysis with upstream regulatory network analysis to investigate mitochondrial energy pathway alterations in a preclinical ovine model of MI. Proteomic profiling of infarcted myocardium revealed a pronounced shift from oxidative phosphorylation to glycolysis, accompanied by coordinated suppression of mitochondrial fatty acid β-oxidation enzymes. This metabolic reprogramming was strongly associated with four upstream master regulators, most notably predicted inhibition and significant transcriptional downregulation of PPARGC1A, a key coactivator of mitochondrial biogenesis and oxidative metabolism, indicating disrupted mitochondrial energy homeostasis and impaired adaptive responses in ischemic cardiomyocytes. Parallel plasma proteomic analysis identified a distinct panel of differentially expressed proteins enriched in pathways related to carbon metabolism, amino acid biosynthesis, and cardiac muscle contraction. Notably, mitochondrial metabolic enzymes such as SUCLG1, MDH2, HADHA, and HADHB were significantly downregulated at both the transcript and protein levels in cardiac tissue, while their protein abundance was markedly increased in plasma post-MI, highlighting their potential as circulating biomarkers of mitochondrial dysfunction. These findings provide mechanistic insight into the energy metabolic remodeling that occurs during myocardial ischemic injury and establish a systems-level framework for linking tissue-specific mitochondrial alterations with accessible plasma biomarkers. This study supports the translational potential of targeting mitochondrial pathways for diagnostic and therapeutic strategies in ischemic heart disease.
线粒体功能障碍是心肌梗死(MI)的一个标志,然而,将缺血心肌中的代谢重编程与全身生物标志物特征联系起来的分子机制仍不完全清楚。在这项研究中,我们采用了数据独立采集质谱(SWATH-MS)策略,将多组学分析与上游调控网络分析相结合,研究了绵羊心肌梗死模型中线粒体能量途径的改变。梗死心肌的蛋白质组学分析显示,心肌梗死从氧化磷酸化到糖酵解发生了明显的转变,并伴有线粒体脂肪酸β-氧化酶的协同抑制。这种代谢重编程与四个上游主调控因子密切相关,最显著的预测是PPARGC1A的抑制和显著的转录下调,PPARGC1A是线粒体生物发生和氧化代谢的关键共激活因子,表明缺血心肌细胞线粒体能量稳态被破坏,适应性反应受损。平行血浆蛋白质组学分析发现,在碳代谢、氨基酸生物合成和心肌收缩相关的途径中富集了一组不同的差异表达蛋白。值得注意的是,心肌组织中SUCLG1、MDH2、HADHA和HADHB等线粒体代谢酶的转录物和蛋白水平均显著下调,而心肌梗死后血浆中这些酶的蛋白丰度显著增加,这凸显了它们作为线粒体功能障碍循环生物标志物的潜力。这些发现为心肌缺血损伤期间发生的能量代谢重塑提供了机制见解,并建立了将组织特异性线粒体改变与可获得的血浆生物标志物联系起来的系统级框架。这项研究支持了靶向线粒体途径在缺血性心脏病诊断和治疗策略中的转化潜力。
{"title":"Mitochondrial metabolic remodeling and multi-omics profiling identify plasma biomarkers of myocardial infarction","authors":"Selvam Paramasivan ,&nbsp;Mitchell C. Lock ,&nbsp;Roberto A. Barrero ,&nbsp;Paul C. Mills ,&nbsp;Janna L. Morrison ,&nbsp;Pawel Sadowski","doi":"10.1016/j.jmccpl.2025.100827","DOIUrl":"10.1016/j.jmccpl.2025.100827","url":null,"abstract":"<div><div>Mitochondrial dysfunction is a hallmark of myocardial infarction (MI), yet the molecular mechanisms linking metabolic reprogramming in the ischemic myocardium to systemic biomarker signatures remain incompletely understood. In this study, we employed a data-independent acquisition mass spectrometry (SWATH-MS) strategy integrating multi-omics analysis with upstream regulatory network analysis to investigate mitochondrial energy pathway alterations in a preclinical ovine model of MI. Proteomic profiling of infarcted myocardium revealed a pronounced shift from oxidative phosphorylation to glycolysis, accompanied by coordinated suppression of mitochondrial fatty acid β-oxidation enzymes. This metabolic reprogramming was strongly associated with four upstream master regulators, most notably predicted inhibition and significant transcriptional downregulation of <em>PPARGC1A</em>, a key coactivator of mitochondrial biogenesis and oxidative metabolism, indicating disrupted mitochondrial energy homeostasis and impaired adaptive responses in ischemic cardiomyocytes. Parallel plasma proteomic analysis identified a distinct panel of differentially expressed proteins enriched in pathways related to carbon metabolism, amino acid biosynthesis, and cardiac muscle contraction. Notably, mitochondrial metabolic enzymes such as <em>SUCLG1</em>, <em>MDH2</em>, <em>HADHA</em>, and <em>HADHB</em> were significantly downregulated at both the transcript and protein levels in cardiac tissue, while their protein abundance was markedly increased in plasma post-MI, highlighting their potential as circulating biomarkers of mitochondrial dysfunction. These findings provide mechanistic insight into the energy metabolic remodeling that occurs during myocardial ischemic injury and establish a systems-level framework for linking tissue-specific mitochondrial alterations with accessible plasma biomarkers. This study supports the translational potential of targeting mitochondrial pathways for diagnostic and therapeutic strategies in ischemic heart disease.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100827"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired PGC-1α-pAMPK signaling in postmenopausal women undergoing cardiac surgery and the role of nicotinamide in its reversal: Insights from a murine model 绝经后妇女心脏手术后PGC-1α-pAMPK信号受损及烟酰胺在其逆转中的作用:来自小鼠模型的见解
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-22 DOI: 10.1016/j.jmccpl.2025.100831
Mark Robitaille , Usman Ahmed , Juan Valencia , Adnan Khan , Adil al-Karim Manji , Elizabeth Russ , Louis Chu , Kamal Khabbaz , Feroze Mahmood , Robina Matyal
Postmenopausal women undergoing cardiac surgery face disproportionately worse outcomes compared with men, a disparity linked to mitochondrial dysfunction following estrogen loss. We investigated sex-specific metabolic responses to cardiac stress in surgical patients and in a murine model of postmenopausal dysfunction, with a focus on proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) signaling and the therapeutic potential of nicotinamide (NAM), a precursor of nicotinamide adenine dinucleotide (NAD+). In a prospective cohort of 102 patients (51 men, 51 women) undergoing cardiac surgery with cardiopulmonary bypass, women exhibited a significantly higher incidence of diastolic dysfunction and longer hospital stays despite comparable baseline characteristics. Molecular analysis of atrial tissue revealed that men demonstrated increased postoperative PGC-1α and phosphorylated AMP-activated protein kinase (pAMPK), while women had reduced expression and also displayed a significant decline in myocardial NAD+ levels. To mechanistically model these findings, ovariectomized mice on a high-fat diet exhibited reduced myocardial PGC-1α and pAMPK expression, suppressed antioxidant defenses, and increased fibrosis. NAM supplementation restored myocardial NAD+, increased PGC-1α expression, and significantly improved systolic and diastolic cardiac function. These findings indicate that loss of estrogen impairs responses to oxidative stress in postmenopausal women, predisposing to adverse outcomes after cardiac stress. NAM may represent a promising non-hormonal strategy to restore mitochondrial function and improve cardiac function. This supports further evaluation of NAD+-boosting therapies as targeted interventions for postmenopausal women at risk of heart failure with preserved ejection fraction.
绝经后接受心脏手术的女性与男性相比面临着不成比例的更差的结果,这种差异与雌激素丢失后的线粒体功能障碍有关。我们研究了外科手术患者和绝经后功能障碍小鼠模型对心脏应激的性别特异性代谢反应,重点关注增殖激活受体γ辅助激活因子1- α (PGC-1α)信号传导和烟酰胺(NAM)的治疗潜力,烟酰胺腺嘌呤二核苷酸(NAD+)的前体。在102例接受心脏手术合并体外循环的患者(51例男性,51例女性)的前瞻性队列研究中,尽管具有相似的基线特征,但女性的舒张功能障碍发生率明显更高,住院时间更长。心房组织分子分析显示,男性术后PGC-1α和磷酸化amp活化蛋白激酶(pAMPK)升高,而女性心肌NAD+水平明显下降。为了对这些发现进行机制模拟,切除卵巢的小鼠在高脂肪饮食中表现出心肌PGC-1α和pAMPK表达降低,抗氧化防御受到抑制,纤维化增加。补充NAM恢复心肌NAD+,增加PGC-1α表达,显著改善心脏收缩和舒张功能。这些研究结果表明,雌激素的丧失会损害绝经后妇女对氧化应激的反应,易导致心脏应激后的不良后果。NAM可能代表了一种有希望的非激素策略来恢复线粒体功能和改善心功能。这支持进一步评估NAD+增强疗法作为有射血分数保留的绝经后心力衰竭风险妇女的靶向干预措施。
{"title":"Impaired PGC-1α-pAMPK signaling in postmenopausal women undergoing cardiac surgery and the role of nicotinamide in its reversal: Insights from a murine model","authors":"Mark Robitaille ,&nbsp;Usman Ahmed ,&nbsp;Juan Valencia ,&nbsp;Adnan Khan ,&nbsp;Adil al-Karim Manji ,&nbsp;Elizabeth Russ ,&nbsp;Louis Chu ,&nbsp;Kamal Khabbaz ,&nbsp;Feroze Mahmood ,&nbsp;Robina Matyal","doi":"10.1016/j.jmccpl.2025.100831","DOIUrl":"10.1016/j.jmccpl.2025.100831","url":null,"abstract":"<div><div>Postmenopausal women undergoing cardiac surgery face disproportionately worse outcomes compared with men, a disparity linked to mitochondrial dysfunction following estrogen loss. We investigated sex-specific metabolic responses to cardiac stress in surgical patients and in a murine model of postmenopausal dysfunction, with a focus on proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) signaling and the therapeutic potential of nicotinamide (NAM), a precursor of nicotinamide adenine dinucleotide (NAD<sup>+</sup>). In a prospective cohort of 102 patients (51 men, 51 women) undergoing cardiac surgery with cardiopulmonary bypass, women exhibited a significantly higher incidence of diastolic dysfunction and longer hospital stays despite comparable baseline characteristics. Molecular analysis of atrial tissue revealed that men demonstrated increased postoperative PGC-1α and phosphorylated AMP-activated protein kinase (pAMPK), while women had reduced expression and also displayed a significant decline in myocardial NAD<sup>+</sup> levels. To mechanistically model these findings, ovariectomized mice on a high-fat diet exhibited reduced myocardial PGC-1α and pAMPK expression, suppressed antioxidant defenses, and increased fibrosis. NAM supplementation restored myocardial NAD<sup>+</sup>, increased PGC-1α expression, and significantly improved systolic and diastolic cardiac function. These findings indicate that loss of estrogen impairs responses to oxidative stress in postmenopausal women, predisposing to adverse outcomes after cardiac stress. NAM may represent a promising non-hormonal strategy to restore mitochondrial function and improve cardiac function. This supports further evaluation of NAD<sup>+</sup>-boosting therapies as targeted interventions for postmenopausal women at risk of heart failure with preserved ejection fraction.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100831"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus 胰岛素使用促进糖尿病患者动脉粥样硬化斑块转录组的促炎改变
IF 2.2 Pub Date : 2025-12-01 Epub Date: 2025-11-16 DOI: 10.1016/j.jmccpl.2025.100829
Angelle Bradford , Tadashi Yoshida , Sergiy Sukhanov , Foster F. Woods , Patrice Delafontaine , Hernan A. Bazan , T. Cooper Woods

Background

Diabetes Mellitus is associated with increased risk of myocardial infarctions and strokes due to accelerated atherosclerotic plaque development and rupture. The mechanisms driving plaque rupture in the diabetic setting remain unclear.

Methods

We sequenced ribosome-depleted total RNA from carotid plaques obtained from diabetic subjects undergoing carotid endarterectomy with high-grade stenosis, who either recently experienced a carotid-related ischemic cerebrovascular event (Symptomatic, n = 6) or had no such event (Asymptomatic, n = 6).

Results

Principal component analysis of the most variable transcripts demonstrated that sex and insulin use, rather than plaque rupture status, were the major contributors to the variability in the dataset. Hierarchical clustering further highlighted the importance of these factors in the dataset but also included two clusters whose expression was elevated in the symptomatic group. These clusters were enriched with transcripts for immunoglobulins and matrix metalloproteinases, suggesting increased B-cell infiltration and extracellular matrix degradation in the symptomatic plaques. We identified only two transcripts, RNU2–1 and PI4KAP1, as significantly up-regulated in the symptomatic group. We identified 35 transcripts with altered expression in subjects on insulin therapy, including regulators of B-cells (MZB1), T cells (BTN3A1, BTN3A2, BTN3A3, CD96, and CTSW), and macrophages (MPEG1). Next, we used spatial deconvolution to focus on differentially expressed genes in the fibrous cap of the carotid plaques. In the symptomatic group, we identified elevated levels of five angiogenesis-associated transcripts (ALS2CL, EPHB4, SMAD1, PREX2, EFNA5), suggesting increased intraplaque neovascularization in ruptured plaques.

Conclusions

Thus, insulin use significantly impacts the transcriptome of atherosclerotic plaques, promoting vascular inflammation.
背景:由于动脉粥样硬化斑块的加速发展和破裂,糖尿病与心肌梗死和中风的风险增加有关。糖尿病患者斑块破裂的机制尚不清楚。方法:我们对接受颈动脉内膜切除术并伴有高度狭窄的糖尿病患者颈动脉斑块中核糖体缺失的总RNA进行测序,这些患者近期经历过颈动脉相关的缺血性脑血管事件(有症状的,n = 6)或没有发生过此类事件(无症状的,n = 6)。结果对最可变转录本的主成分分析表明,性别和胰岛素使用,而不是斑块破裂状态,是数据集中可变性的主要因素。分层聚类进一步强调了这些因素在数据集中的重要性,但也包括两个在症状组中表达升高的聚类。这些团簇富含免疫球蛋白和基质金属蛋白酶的转录本,表明有症状斑块中b细胞浸润和细胞外基质降解增加。我们发现只有两个转录本RNU2-1和PI4KAP1在症状组中显著上调。我们在胰岛素治疗的受试者中发现了35个表达改变的转录本,包括b细胞(MZB1)、T细胞(BTN3A1、BTN3A2、BTN3A3、CD96和CTSW)和巨噬细胞(MPEG1)的调节因子。接下来,我们使用空间反褶积来关注颈动脉斑块纤维帽中的差异表达基因。在有症状组,我们发现5种血管生成相关转录物(ALS2CL、EPHB4、SMAD1、PREX2、EFNA5)水平升高,表明破裂斑块斑块内新生血管增加。因此,胰岛素使用显著影响动脉粥样硬化斑块的转录组,促进血管炎症。
{"title":"Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus","authors":"Angelle Bradford ,&nbsp;Tadashi Yoshida ,&nbsp;Sergiy Sukhanov ,&nbsp;Foster F. Woods ,&nbsp;Patrice Delafontaine ,&nbsp;Hernan A. Bazan ,&nbsp;T. Cooper Woods","doi":"10.1016/j.jmccpl.2025.100829","DOIUrl":"10.1016/j.jmccpl.2025.100829","url":null,"abstract":"<div><h3>Background</h3><div>Diabetes Mellitus is associated with increased risk of myocardial infarctions and strokes due to accelerated atherosclerotic plaque development and rupture. The mechanisms driving plaque rupture in the diabetic setting remain unclear.</div></div><div><h3>Methods</h3><div>We sequenced ribosome-depleted total RNA from carotid plaques obtained from diabetic subjects undergoing carotid endarterectomy with high-grade stenosis, who either recently experienced a carotid-related ischemic cerebrovascular event (Symptomatic, <em>n</em> = 6) or had no such event (Asymptomatic, n = 6).</div></div><div><h3>Results</h3><div>Principal component analysis of the most variable transcripts demonstrated that sex and insulin use, rather than plaque rupture status, were the major contributors to the variability in the dataset. Hierarchical clustering further highlighted the importance of these factors in the dataset but also included two clusters whose expression was elevated in the symptomatic group. These clusters were enriched with transcripts for immunoglobulins and matrix metalloproteinases, suggesting increased B-cell infiltration and extracellular matrix degradation in the symptomatic plaques. We identified only two transcripts, <em>RNU2–1</em> and <em>PI4KAP1</em>, as significantly up-regulated in the symptomatic group. We identified 35 transcripts with altered expression in subjects on insulin therapy, including regulators of B-cells (<em>MZB1</em>), T cells (<em>BTN3A1, BTN3A2, BTN3A3, CD96</em>, and <em>CTSW</em>), and macrophages (<em>MPEG1</em>). Next, we used spatial deconvolution to focus on differentially expressed genes in the fibrous cap of the carotid plaques. In the symptomatic group, we identified elevated levels of five angiogenesis-associated transcripts (<em>ALS2CL, EPHB4, SMAD1, PREX2, EFNA5</em>), suggesting increased intraplaque neovascularization in ruptured plaques.</div></div><div><h3>Conclusions</h3><div>Thus, insulin use significantly impacts the transcriptome of atherosclerotic plaques, promoting vascular inflammation.</div></div>","PeriodicalId":73835,"journal":{"name":"Journal of molecular and cellular cardiology plus","volume":"14 ","pages":"Article 100829"},"PeriodicalIF":2.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of molecular and cellular cardiology plus
全部 Geobiology Appl. Clay Sci. Geochim. Cosmochim. Acta J. Hydrol. Org. Geochem. Carbon Balance Manage. Contrib. Mineral. Petrol. Int. J. Biometeorol. IZV-PHYS SOLID EART+ J. Atmos. Chem. Acta Oceanolog. Sin. Acta Geophys. ACTA GEOL POL ACTA PETROL SIN ACTA GEOL SIN-ENGL AAPG Bull. Acta Geochimica Adv. Atmos. Sci. Adv. Meteorol. Am. J. Phys. Anthropol. Am. J. Sci. Am. Mineral. Annu. Rev. Earth Planet. Sci. Appl. Geochem. Aquat. Geochem. Ann. Glaciol. Archaeol. Anthropol. Sci. ARCHAEOMETRY ARCT ANTARCT ALP RES Asia-Pac. J. Atmos. Sci. ATMOSPHERE-BASEL Atmos. Res. Aust. J. Earth Sci. Atmos. Chem. Phys. Atmos. Meas. Tech. Basin Res. Big Earth Data BIOGEOSCIENCES Geostand. Geoanal. Res. GEOLOGY Geosci. J. Geochem. J. Geochem. Trans. Geosci. Front. Geol. Ore Deposits Global Biogeochem. Cycles Gondwana Res. Geochem. Int. Geol. J. Geophys. Prospect. Geosci. Model Dev. GEOL BELG GROUNDWATER Hydrogeol. J. Hydrol. Earth Syst. Sci. Hydrol. Processes Int. J. Climatol. Int. J. Earth Sci. Int. Geol. Rev. Int. J. Disaster Risk Reduct. Int. J. Geomech. Int. J. Geog. Inf. Sci. Isl. Arc J. Afr. Earth. Sci. J. Adv. Model. Earth Syst. J APPL METEOROL CLIM J. Atmos. Oceanic Technol. J. Atmos. Sol. Terr. Phys. J. Clim. J. Earth Sci. J. Earth Syst. Sci. J. Environ. Eng. Geophys. J. Geog. Sci. Mineral. Mag. Miner. Deposita Mon. Weather Rev. Nat. Hazards Earth Syst. Sci. Nat. Clim. Change Nat. Geosci. Ocean Dyn. Ocean and Coastal Research npj Clim. Atmos. Sci. Ocean Modell. Ocean Sci. Ore Geol. Rev. OCEAN SCI J Paleontol. J. PALAEOGEOGR PALAEOCL PERIOD MINERAL PETROLOGY+ Phys. Chem. Miner. Polar Sci. Prog. Oceanogr. Quat. Sci. Rev. Q. J. Eng. Geol. Hydrogeol. RADIOCARBON Pure Appl. Geophys. Resour. Geol. Rev. Geophys. Sediment. Geol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1